Medical equipment industry
Johnson & Johnson Weighs Options on Guidant Deal Over Defibrillator Issues
Johnson & Johnson, which recently agreed to buy Guidant for $25.4 billion, is assessing whether issues with Guidant's heart devices and its response to them constitute a "materially adverse change" to Guidant's business. If the problems are deemed damaging, Johnson & Johnson could